1[1]Vleggaar FP,Van Ooteghem NA,Van Buuren HR,et al.Cholestatic liver diseases:slow progress in understanding and treating slowly progressive disorders.Scand J Gastroenterol,2000,232(Suppl):86
2[2]Heathcote EJ.Management of primary biliary cirrhosis.The American Association for the study of liver diseases practice guidelines.Hepatology,2000,31:1005
4[4]Longo M,Crosignani A,Battezzati PM,et al.Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis.Gut,2002,51:265
5[5]Del Puppo M,Galli KM,Crosignani A,et al.Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration.J Lipid Res,2001,42:437
6[6]Balan V,Dickson ER,Jorgensen RA,et al.Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis.Mayo Clin Proc,1994,69:923
8Liu H,Liu Y,Wang L. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China[J].Bmc Gastroenterology,2010.100.
9Heathcote E J. Management of primary biliary cirrhosis.The American association for the study of liver diseases practice guidelines[J].Hepatology,2000,(04):1005-1013.
